Breaking News Headlines Today | Ground News

Black Friday Sale - Get 40% off Vantage

Express Pharma image

News from Express Pharma

Ground News rates Express Pharma’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

Sun Pharma Receives US FDA Label Update Approval for UNLOXCYT

Richmond, Kentucky · Richmond

Sun Pharma Receives US FDA Label Update Approval for UNLOXCYT

77% Center coverage: 22 sources

Sun Pharmaceutical announced the US Food and Drug Administration (FDA) approved an updated label for UNLOXCYT (cosibelimab-ipdl) for the treatment of adults with metastatic CSCC or locally advanced CSCC who are not candidates for curative surgery or curative radiation. The updated label now incorporates long-term follow-up data from the pivotal CK-301-101 trial, a multicenter, multicohort, open-label study of 109 patients (31 with laCSCC; 78…See the Story

Zydus and RK Pharma Sign Exclusive Licensing Deal for Novel Oncology Product in USA

United States · United States

Zydus and RK Pharma Sign Exclusive Licensing Deal for Novel Oncology Product in USA

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it has entered into an exclusive licensing and commercialisation agreement with RK Pharma Inc. of the US for a novel sterile injectable 505(b)(2) oncology supportive care product for the US market. Under the terms of this agreement, RK Pharma […] The post Zydus and RK Pharma Sign Exclusive Licensing Deal for No…See the Story

Zydus Lifesciences Gains US FDA Approval for Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg Dosages

United States · United States

Zydus Lifesciences Gains US FDA Approval for Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg Dosages

Zydus Lifesciences Limited has obtained final approval […] The post Zydus Lifesciences Gains US FDA Approval for Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg Dosages first appeared on GeneOnline News. The post Zydus Lifesciences Gains US FDA Approval for Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg Dosages appeared first on GeneOnline News.See the Story

Breaking News Topics Related to Express Pharma